Dae Chul Jung

Yonsei University

Papers

3

Total Citations

56

H-Index

3

About

Dr. Dae Chul Jung is a leading urologic surgeon whose research focuses on advancing robotic surgical techniques for prostate and kidney cancers. His work has significantly shaped the management of high-risk prostate cancer, demonstrating through his 2014 study (24 citations) that robot-assisted radical prostatectomy with pelvic lymph node dissection is a feasible and effective treatment option for men aged 70 and older with very-high-risk disease—a population often considered challenging for surgery. In the realm of kidney cancer, Dr. Jung has pioneered efforts to preserve renal function. His 2015 study (17 citations) utilized three-dimensional segmentation technology to predict long-term renal function and contralateral hypertrophy after robot-assisted partial nephrectomy, providing critical insights for surgical planning. Furthermore, he introduced a simplified zero ischemia technique in robot-assisted partial nephrectomy (2013, 15 citations), enhancing safety by minimizing kidney damage during tumor removal. Dr. Jung’s contributions have been instrumental in refining minimally invasive urologic oncology, improving outcomes for patients with complex conditions.

Research Focus

Key Achievements

3
H-Index
3
Papers
56
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Feasibility of robot-assisted radical prostatectomy for very-high risk prostate cancer: surgical and oncological outcomes in men aged ≥70 years
24 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Yonsei University

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago